Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco/Reader's Digest Consumer PBM Plan Offers 18% Discount On Mail Rxs

Executive Summary

The Merck-Medco/Reader's Digest consumer discount plan offers enrollees an average discount of 18% for mail-service prescriptions, Merck-Medco said.

You may also be interested in...



YOURxPLAN or MyRxPlan?

Merck-Medco "YOURxPLAN" is no longer marketed by Reader's Digest. The promotional agreement for the senior discount card program came to an end last fall; Merck-Medco said that the decision reflected the changing environment for card programs in light of the proposal by the Bush Administration for a Medicare-endorsed card system. The "YOURxPLAN" was launched in April 2000 (1"The Pink Sheet" April 24, 2000, p. 29)...

YOURxPLAN or MyRxPlan?

Merck-Medco "YOURxPLAN" is no longer marketed by Reader's Digest. The promotional agreement for the senior discount card program came to an end last fall; Merck-Medco said that the decision reflected the changing environment for card programs in light of the proposal by the Bush Administration for a Medicare-endorsed card system. The "YOURxPLAN" was launched in April 2000 (1"The Pink Sheet" April 24, 2000, p. 29)...

Massachusetts Senior Rx Plan Nears Selection Of PBM To Administer Program

Massachusetts expects to select a pharmacy benefit management company by the end of January for the state's prescription drug insurance program for the elderly. The Rx plan is scheduled to be operational in the second quarter of 2001.

Related Content

UsernamePublicRestriction

Register

PS035932

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel